| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Frazier Life Sciences Acquisition Corp. II
13D
G37103101
|
20.5% |
10/21/2026
Event 10/15/2026
|
||||
| Frazier Life Sciences Holdings II LLC | 20.5% | |||||
| Albert Cha | 20.5% | |||||
| Frazier Life Sciences Public Fund, L.P. | 20.5% | |||||
| FHMLSP, L.P. | 20.5% | |||||
| FHMLSP, L.L.C. | 20.5% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.